Get access
Advertisement

Medication with antihistamines impairs allergen-specific immunotherapy in mice

Authors

  • P. Johansen,

    1. Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Search for more papers by this author
  • G. Senti,

    1. Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    2. Clinical Trials Center, Center for Clinical Research, University Hospital of Zurich, Zurich, Switzerland
    Search for more papers by this author
  • J. Maria Martínez Gómez,

    1. Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Search for more papers by this author
  • T. M. Kündig

    1. Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Search for more papers by this author

Correspondence:
Pål Johansen, Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich 8091, Switzerland.
E-mail: pal.johansen@usz.ch

Summary

Background Histamine released from activated mast cells and basophils is an important mediator in allergy. Therefore, antihistamines are efficiently and widely used to suppress allergic symptoms.

Objective This study evaluated the role of antihistamines in sensitization against allergens and in the efficiency of allergen-specific immunotherapy.

Methods CBA mice were sensitized and de-sensitized with bee venom allergen extracts and the major allergen phospholipase A2. Clemastine was used to test the effect of a histamine-1 receptor antagonist on the immune responses to phospholipase A2.

Results The results demonstrated that sensitization against bee venom was strongly enhanced during treatment with antihistamines. Clemastine increased IgE production while decreasing IgG2a production against bee venom. This T-helper type 2 shift of the humoral response appeared to be caused by reduced IFN-γ and enhanced IL-4 secretion from allergen-specific T cells. We also found reduced TNF-α, IL-6 and major histocompatibility complex class-II expression by macrophages. In sensitized mice, the efficiency of allergen-specific immunotherapy was reduced by clemastine treatment.

Conclusion Antihistamines may enhance allergic sensitization and reduce the efficiency of allergen-specific immunotherapy. Future studies will need to demonstrate to what extent pre-medication with antihistamine also affects allergen-specific immunotherapy in humans.

Get access to the full text of this article

Ancillary